Pharma channel feed – Endpoints News

Pharma channel feed

FDA experts offer a big thumbs up for J&J’s flawed application for ketamine-based depression drug — but trial failures, safety questions spur concerns

7 years ago

The high rollers: The top 20 blockbuster biopharma deals of the past decade

7 years ago

FDA targets products falsely claiming to treat Alzheimer’s disease

7 years ago

FDA promises speedy review on moving Merck's Keytruda up as first-line head and neck cancer therapy

7 years ago

Top 20 biotech deals: 2019 dealmaking gets off to a roaring start, building on a record amount for '18

7 years ago

AbbVie jumps into the frenzied race for a BCMA/CD3 bispecific targeting multiple myeloma. Teneobio who?

7 years ago

Regeneron, Sanofi slash Praluent list price mirroring Repatha discount

7 years ago

Macromolecules in a pill? Tortoise-inspired capsule offers hope in an early test delivering insulin into stomach wall

7 years ago

Should J&J win an OK for a flawed depression drug after notable trial failures? FDA review offers a path forward

7 years ago

As magnitude and frequency of drug price hikes thaw, Express Scripts reports lowest increase in spending by commercial plans in 25 years

7 years ago

Burnishing its rare disease drug ambitions, Sanofi picks up fast FDA OK for Cablivi — courtesy of a $4.8B buyout

7 years ago

Capricor to resume dosing in DMD trial — but scarce resources force company to pause enrollment, cut jobs

7 years ago

To tackle superbug scourge and revive R&D, incentivize FDA antibiotic approvals — drugmakers, health groups urge US lawmakers

7 years ago

Say what? Trump declares a big victory in the war on drug prices — for December, anyhow

7 years ago

After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck

7 years ago

As Herceptin biosimilars eat into Roche sales, Swiss drugmaker makes case for expanded Kadcyla use

7 years ago

In a field littered with failures, positive data prompt speedy US, EU review of AstraZeneca's long-acting RSV drug

7 years ago

Shakeup at the top of FDA’s biosimilars division as Leah Christl departs for Amgen

7 years ago

Baeuerle-backed Cullinan grows its pipeline of portfolio plays, adopts a new cancer drug with eye to clinical development

7 years ago

Evolus celebrates greenlight for Botox rival while Allergan counterattacks with a complaint of stolen trade secrets

7 years ago

Alkermes shares take another hit as the FDA shakes its head — again — on a weak case for '5461

7 years ago

MPs threaten to hijack Vertex’s IP for its cystic fibrosis drugs in a long-running standoff over price

7 years ago

Novo bets on swift FDA review for oral diabetes drug semaglutide

7 years ago

Trump administration proposes new rules that strip away many of the rebate deals between pharma and PBMs, pushing discounts to consumers

7 years ago

First page Previous page 280 281 282283284 285 286 Next page Last page